This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jan;171(1):119-20.

doi: 10.1176/appi.ajp.2013.13091193r.

Response to Rosenfeld

L Fredrik Jarskog, T Scott Stroup

PMID: 24399433
DOI: 10.1176/appi.ajp.2013.13091193r

Comment

Response to Rosenfeld

L Fredrik Jarskog et al. Am J Psychiatry. 2014 Jan.

. 2014 Jan;171(1):119-20.

doi: 10.1176/appi.ajp.2013.13091193r.

Authors

L Fredrik Jarskog, T Scott Stroup

PMID: 24399433
DOI: 10.1176/appi.ajp.2013.13091193r

No abstract available

PubMed Disclaimer

Comment on

Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder.
Jarskog LF, Hamer RM, Catellier DJ, Stewart DD, Lavange L, Ray N, Golden LH, Lieberman JA, Stroup TS; METS Investigators. Jarskog LF, et al. Am J Psychiatry. 2013 Sep;170(9):1032-40. doi: 10.1176/appi.ajp.2013.12010127. Am J Psychiatry. 2013. PMID: 23846733 Free PMC article. Clinical Trial.
Metformin and Alzheimer's disease risk.
Rosenfeld JE. Rosenfeld JE. Am J Psychiatry. 2014 Jan;171(1):119. doi: 10.1176/appi.ajp.2013.13091193. Am J Psychiatry. 2014. PMID: 24399432 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information